HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gasiewicz, T. A. Articles by Bauman, P. A. Search for Related Content PubMed PubMed Citation Articles by Gasiewicz, T. A. Articles by Bauman, P. A. Social Bookmarking                      What's this?

J. Biol. Chem., Vol. 262, Issue 5, 2116-2120, 02, 1987

Heterogeneity of the rat hepatic Ah receptor and evidence for transformation in vitro and in vivo

TA Gasiewicz and PA Bauman

The characteristics of the Ah receptor from rat liver were investigated following the incubation of cytosol with [3H]2,3,7,8-tetrachlorodibenzo- p-dioxin (TCDD) under various conditions, and using DEAE- and DNA- Sepharose chromatography and sucrose density gradient centrifugation. These studies indicated that the Ah receptor can exist in three distinct forms in vitro that are dependent on the presence or absence of TCDD and the duration and temperature of incubation. The unoccupied receptor was distinguished by its elution from DEAE-Sepharose columns at 0.20-0.23 M NaCl and lack of affinity for DNA-Sepharose. Following the incubation of the unoccupied receptor with [3H]TCDD, two occupied forms were distinguished based on their overall surface charges and affinities for DNA. One of these forms was predominant following short incubations (2 h) with [3H]TCDD at a low temperature (0 degree C) and was characterized by having the same elution profile on DEAE-Sepharose as the unoccupied form, but demonstrated some affinity for DNA. Another occupied form was predominant following an incubation for a longer time (20 h, 0 degree C) or at an elevated temperature (2 h, 20 degrees C). This form had an overall surface charge that was less negative and a greater affinity for DNA. These changes in receptor characteristics were dependent on the presence of TCDD and were not accompanied by apparent changes in the sedimentation coefficients of the two occupied forms. Anion exchange chromatography of the [3H]TCDD-receptor complex extracted from hepatic nuclei of [3H]TCDD-treated rats indicated that the ligand-induced change of the unoccupied receptor to a less negatively charged form had occurred in vivo. These results indicated a biochemical heterogeneity of the Ah receptor and suggested the occurrence of a ligand- and temperature-dependent transformation process in vivo and in vitro.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. B. Okey An Aryl Hydrocarbon Receptor Odyssey to the Shores of Toxicology: The Deichmann Lecture, International Congress of Toxicology-XI Toxicol. Sci., July 1, 2007; 98(1): 5 - 38. [Abstract] [Full Text] [PDF]

				A. Joiakim, P. A. Mathieu, A. A. Elliott, and J. J. Reiners Jr. Superinduction of CYP1A1 in MCF10A Cultures by Cycloheximide, Anisomycin, and Puromycin: A Process Independent of Effects on Protein Translation and Unrelated to Suppression of Aryl Hydrocarbon Receptor Proteolysis by the Proteasome Mol. Pharmacol., October 1, 2004; 66(4): 936 - 947. [Abstract] [Full Text] [PDF]

				A. Joiakim, P. A. Mathieu, C. Palermo, T. A. Gasiewicz, and J. J. Reiners Jr. THE JUN N-TERMINAL KINASE INHIBITOR SP600125 IS A LIGAND AND ANTAGONIST OF THE ARYL HYDROCARBON RECEPTOR Drug Metab. Dispos., November 1, 2003; 31(11): 1279 - 1282. [Abstract] [Full Text] [PDF]

				E. C. Henry, A. S. Kende, G. Rucci, M. J. Totleben, J. J. Willey, S. D. Dertinger, R. S. Pollenz, J. P. Jones, and T. A. Gasiewicz Flavone Antagonists Bind Competitively with 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) to the Aryl Hydrocarbon Receptor But Inhibit Nuclear Uptake and Transformation Mol. Pharmacol., April 1, 1999; 55(4): 716 - 725. [Abstract] [Full Text]